On November 19, Molina Healthcare fell 4.14% in Regular Trading, trading at $198.71 per share, with turnover of $20.4677 million.
The move followed continued pressure on managed care insurers after CMS proposed tighter anti-fraud and improper-payment rules affecting Medicare Advantage and Medicaid, extending the prior session’s weakness across the group.
The proposal would expand Medicare Advantage audit scope, increase audit frequency, strengthen enrollment safeguards, and tighten scrutiny of deductions from Medicaid payments. Recent sector trading reflected those concerns, with UnitedHealth down 5.13%, Centene down 5.01%, Elevance Health down 3.49%, and Humana down 2.29%. Earlier policy relief from a temporary Medicaid work-rule enforcement delay had supported Molina Healthcare, but that effect has been overtaken by renewed regulatory overhang.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments